Al Owaifeer Adi Mohammed, Almutairi Abdulsalam Tayi, Schargel Konrad
King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia; Ophthalmology Unit, Department of Surgery, College of Medicine, King Faisal University, Al-Ahsa, Saudi Arabia.
King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia; Department of Ophthalmology, King Abdulaziz Hospital, National Guard Health Affairs. Al Ahsa, Saudi Arabia.
J AAPOS. 2022 Apr;26(2):78.e1-78.e5. doi: 10.1016/j.jaapos.2021.11.013. Epub 2022 Mar 17.
To report the outcomes of trans-scleral cyclophotocoagulation (TSCPC) in pediatric glaucoma secondary to Sturge-Weber syndrome (SWS).
The medical records of all SWS glaucoma cases in the pediatric age group (<18 years of age) that underwent TSCPC at our institute from January 2000 to September 2017.
A total of 22 eyes of 22 patients were included. Mean age at the time of TSCPC was 5.9 ± 5 years (range, 0-16 years). Mean postoperative follow-up was 32.2 ± 16.6 months (range, 6-54 months). Intraocular pressure (IOP) was reduced from a preoperative mean of 28 ± 4.5 mm Hg to 20.3 ± 3.7 mm Hg at 36 months (P = 0.02). The mean number of glaucoma medications used was 3.5 ± 0.7 preoperatively and 3.1 ± 1.4 at 36 months (P = 0.70). The overall success rate (complete and qualified) was 72.7% at 12 months, 62.3% at 24 months, and 54.5% at 36 months. One eye developed hypotony and choroidal effusion, which resolved with medical therapy. Of the patients for whom visual acuity was recorded preoperatively, no one experienced a loss of more than 2 lines of Snellen visual acuity.
In our study cohort, TSCPC resulted in mild reduction in IOP, with minimal complications.
报告经巩膜睫状体光凝术（TSCPC）治疗小儿斯-韦综合征（SWS）继发性青光眼的疗效。
回顾性分析2000年1月至2017年9月在我院接受TSCPC治疗的小儿年龄组（<18岁）所有SWS青光眼病例的病历资料。
共纳入22例患者的22只眼。TSCPC时的平均年龄为5.9±5岁（范围0 - 16岁）。术后平均随访时间为32.2±16.6个月（范围6 - 54个月）。眼压（IOP）从术前平均28±4.5 mmHg降至36个月时的20.3±3.7 mmHg（P = 0.02）。术前使用青光眼药物的平均数量为3.5±0.7种，36个月时为3.1±1.4种（P = 0.70）。12个月时总体成功率（完全成功和合格）为72.7%，24个月时为62.3%，36个月时为54.5%。1只眼发生低眼压和脉络膜渗漏，经药物治疗后缓解。术前记录视力的患者中，无人视力下降超过2行Snellen视力。
在我们的研究队列中，TSCPC导致眼压轻度降低，并发症极少。
